Cargando…

Potent mouse monoclonal antibodies that block SARS-CoV-2 infection

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has developed into a global pandemic since its first outbreak in the winter of 2019. An extensive investigation of SARS-CoV-2 is critical for disease control. Various recombinant monoclonal a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Youjia, Kawaguchi, Atsushi, Takeshita, Masaru, Sekiya, Takeshi, Hirohama, Mikako, Yamashita, Akio, Siomi, Haruhiko, Murano, Kensaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Accelerated Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846482/ https://www.ncbi.nlm.nih.gov/pubmed/33524396 http://dx.doi.org/10.1016/j.jbc.2021.100346

Ejemplares similares

The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines
por: Murano, Kensaku, et al.
Publicado: (2021)

Transcription of MERVL retrotransposons is required for preimplantation embryo development
por: Sakashita, Akihiko, et al.
Publicado: (2023)

TDP-43 safeguards the embryo genome from L1 retrotransposition
por: Li, Ten D., et al.
Publicado: (2022)

Mitotic phosphorylation of CCCTC‐binding factor (CTCF) reduces its DNA binding activity
por: Sekiya, Takeshi, et al.
Publicado: (2017)

Piwi suppresses transcription of Brahma-dependent transposons via Maelstrom in ovarian somatic cells
por: Onishi, Ryo, et al.
Publicado: (2020)

Influenza Virus Induces Cholesterol-Enriched Endocytic Recycling Compartments for Budozone Formation via Cell Cycle-Independent Centrosome Maturation
por: Kawaguchi, Atsushi, et al.
Publicado: (2015)

Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope “tags”
por: Percival-Alwyn, Jennifer L, et al.
Publicado: (2014)

Isolation of Genomic DNA Controlling Mouse Melanoma Antigen Defined by Monoclonal Antibody
por: Okitsu, Akira, et al.
Publicado: (1988)

Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection
por: Takemori, Toshitada, et al.
Publicado: (2022)

Inhibition of Influenza Virus Infection by Lentinus edodes Mycelia Extract Through Its Direct Action and Immunopotentiating Activity
por: Kuroki, Takahiro, et al.
Publicado: (2018)

Oseltamivir Expands Quasispecies of Influenza Virus through Cell-to-cell Transmission
por: Mori, Kotaro, et al.
Publicado: (2015)

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
por: Shingai, Masashi, et al.
Publicado: (2014)

Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission
por: Challenger, Joseph D, et al.
Publicado: (2023)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes
por: Fabra-García, Amanda, et al.
Publicado: (2023)

piRNA clusters and open chromatin structure
por: Yamanaka, Soichiro, et al.
Publicado: (2014)

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding
por: Sapparapu, Gopal, et al.
Publicado: (2016)

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
por: Ivanochko, Danton, et al.
Publicado: (2023)

A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
por: Katagiri, Takenobu, et al.
Publicado: (2023)

TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility
por: Sekiya, Takeshi, et al.
Publicado: (2022)

Processing of Pre-microRNAs by the Dicer-1–Loquacious Complex in Drosophila Cells
por: Saito, Kuniaki, et al.
Publicado: (2005)

Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies
por: Scott, Martin J., et al.
Publicado: (2020)

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
por: Andreano, Emanuele, et al.
Publicado: (2021)

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
por: Chen, Yuning, et al.
Publicado: (2021)

Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant
por: Wang, Zhaoqian, et al.
Publicado: (2022)

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023)

POTENT AND SELECTIVE A2AR MONOCLONAL ANTIBODY ANTAGONIST FOR THE TREATMENT OF CANCER
por: Hu, Changyun, et al.
Publicado: (2023)

Is canalization more than just a beautiful idea?
por: Sato, Kaoru, et al.
Publicado: (2010)

A monoclonal antibody that blocks adhesion of Chlamydomonas mt+ gametes
Publicado: (1986)

Structural and functional characterization of a monoclonal antibody blocking TIGIT
por: Jeong, Bo-Seong, et al.
Publicado: (2022)

Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo
por: Lund, Ida K., et al.
Publicado: (2012)

Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021)

Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
por: Katagiri, Takenobu, et al.
Publicado: (2023)

Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
por: Noda, Megumi, et al.
Publicado: (2012)

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
por: Vigil, Adam, et al.
Publicado: (2018)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
por: Fan, Pengfei, et al.
Publicado: (2020)

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
por: Rappazzo, C. Garrett, et al.
Publicado: (2021)

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis
por: Kim, Pan Kyeom, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p2i8at01kjkojg2lcm7ior2hko